{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:27:11Z","timestamp":1748492831779,"version":"3.32.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.msard.2021.103450","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T22:57:37Z","timestamp":1638745057000},"page":"103450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["COVID-19 Vaccine intent in appalachian patients with multiple sclerosis"],"prefix":"10.1016","volume":"57","author":[{"given":"Hongyan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlyn","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Umer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Health Disparities in Appalachia Executive Summary","key":"10.1016\/j.msard.2021.103450_bib0001"},{"year":"2020","series-title":"Rural Appalachia Compared to the Rest of Rural America","key":"10.1016\/j.msard.2021.103450_bib0002"},{"issue":"25","key":"10.1016\/j.msard.2021.103450_bib0003","doi-asserted-by":"crossref","first-page":"928","DOI":"10.15585\/mmwr.mm7025e2","article-title":"COVID-19 vaccination coverage and intent among adults aged 18-39 Years - United States, March-May 2021","volume":"70","author":"Baack","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"year":"2021","series-title":"Census Bureau Releases New Educational Attainment Data","key":"10.1016\/j.msard.2021.103450_bib0004"},{"year":"2010","series-title":"Rural America","key":"10.1016\/j.msard.2021.103450_bib0005"},{"key":"10.1016\/j.msard.2021.103450_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117147","article-title":"COVID-19 in multiple sclerosis patients and risk factors for severe infection","volume":"418","author":"Chaudhry","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"23","key":"10.1016\/j.msard.2021.103450_bib0008","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2021.8246","article-title":"Public trust and willingness to vaccinate against COVID-19 in the US From October 14, 2020, to March 29, 2021","volume":"325","author":"Daly","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.msard.2021.103450_bib0009","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the United States commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2021.103450_bib0010","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: an overview","volume":"9","author":"Dube","year":"2013","journal-title":"Hum. Vacc. Immunother."},{"key":"10.1016\/j.msard.2021.103450_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103163","article-title":"COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: a follow up survey during the initial vaccine rollout in 2021","volume":"54","author":"Ehde","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2021.103450_bib0012","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/M20-3569","article-title":"Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. Adults","volume":"173","author":"Fisher","year":"2020","journal-title":"Ann. Intern. Med."},{"year":"2021","series-title":"How West Virginia became a U.S. Leader in Vaccine Rollout. The New York Times","key":"10.1016\/j.msard.2021.103450_bib0013"},{"issue":"1","key":"10.1016\/j.msard.2021.103450_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9010012","article-title":"Safety of newer disease modifying therapies in multiple sclerosis","volume":"9","author":"Jalkh","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.msard.2021.103450_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577599","article-title":"Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients","volume":"356","author":"Kelly","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2021.103450_bib0016","unstructured":"KFF. Vaccine Monitor: some Who Were Hesitant to Get a Vaccine in January Say They Changed Their Mind Because of Family, Friends and Their Personal Doctors. https:\/\/www.kff.org\/coronavirus-covid-19\/press-release\/vaccine-monitor-some-who-were-hesitant-to-get-a-vaccine-in-january-say-they-changed-their-mind-because-of-family-friends-and-their-personal-doctors\/. Published 2021. Updated July 13, 2021. Accessed August 1, 2021."},{"issue":"2","key":"10.1016\/j.msard.2021.103450_bib0017","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10900-020-00958-x","article-title":"COVID-19 vaccination hesitancy in the United States: a rapid national assessment","volume":"46","author":"Khubchandani","year":"2021","journal-title":"J. Commun. Health"},{"issue":"10","key":"10.1016\/j.msard.2021.103450_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25594","article-title":"Factors associated with US adults\u2019 likelihood of accepting COVID-19 vaccination","volume":"3","author":"Kreps","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.msard.2021.103450_bib0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","article-title":"A comprehensive review of the global efforts on COVID-19 vaccine development","volume":"7","author":"Li","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"34","key":"10.1016\/j.msard.2021.103450_bib0020","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.msard.2021.103450_bib0021","first-page":"327","article-title":"Uptake and attitudes about immunizations in people with multiple sclerosis","volume":"11","author":"Marrie","year":"2021","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.msard.2021.103450_bib0022","doi-asserted-by":"crossref","first-page":"759","DOI":"10.15585\/mmwr.mm7020e3","article-title":"Disparities in COVID-19 vaccination coverage between urban and rural counties - United States, December 14, 2020-April 10, 2021","volume":"70","author":"Murthy","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"year":"2021","series-title":"The Appalachian region: a data overview from the 2015-2019 American Community Survey Chartbook","author":"Pollard","key":"10.1016\/j.msard.2021.103450_bib0023"},{"issue":"8","key":"10.1016\/j.msard.2021.103450_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18084374","article-title":"Factors associated with COVID-19 vaccine hesitancy among people with epilepsy in Lithuania","volume":"18","author":"Puteikis","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"42","key":"10.1016\/j.msard.2021.103450_bib0025","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1016\/j.vaccine.2020.08.043","article-title":"Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated?","volume":"38","author":"Reiter","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2021.103450_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577627","article-title":"Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: an international consensus statement","volume":"357","author":"Reyes","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.msard.2021.103450_bib0027","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.vaccine.2021.01.010","article-title":"Predictors of intention to vaccinate against COVID-19: results of a nationwide survey","volume":"39","author":"Ruiz","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2021.103450_bib0028","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012753","article-title":"Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis","author":"Simpson-Yap","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2021.103450_bib0029","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821007161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821007161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T16:37:29Z","timestamp":1735576649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821007161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":28,"alternative-id":["S2211034821007161"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103450","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 Vaccine intent in appalachian patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103450"}}